USPTO serial 79329638
ABOGENBIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 15, 2025
- Examiner
- HARMON, RAYMOND E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ABOGENBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
THOMAS HOXIE
THOMAS HOXIE HOXIE & ASSOCIATES LLC75 MAIN STREETSUITE 203MILLBURN, NJ 07041Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment or prevention of cancer, and infectious diseases; chemico-pharmaceutical preparations for the treatment or prevention of cancer and infectious diseases; drugs being pharmaceutical preparations for medical purposes for the treatment or prevention of cancer and infectious diseases; biological preparations for the treatment or prevention of cancer and infectious diseases for medical purposes; medicines for the treatment or prevention of cancer and infectious diseases for human purposes; chemical preparations for medical purposes, namely, for the treatment or prevention of cancer and infectious diseases; crude drug being homeopathic pharmaceuticals for the treatment of infectious viral diseases;, lipid particle for nucleotide drug delivery purpose for the treatment or prevention of cancer and infectious diseases; and biochemical medicines for the treatment or prevention of cancer and infectious diseases; dietetic substances being foods and beverages adapted for medical use for the treatment or prevention of cancer and infectious diseases | ACTIVE | — |
| 042 | Technological research in the field of medical research, specifically for the treatment or prevention of cancer and infectious diseases; quality control, specifically for products for the treatment or prevention of cancer and infectious disease; product quality testing, specifically for products for the treatment or prevention of cancer and infectious diseases; cancer research for medical purposes; pharmaceutical drug development services, specifically for pharmaceutical drugs for the treatment or prevention of cancer and infectious diseases; pharmaceutical product evaluation, namely, drug evaluation, specifically for the treatment or prevention of cancer and infectious diseases; pharmaceutical research services, specifically for products for the treatment or prevention of cancer and infectious diseases; medical research, specifically for the treatment or prevention of cancer and infectious diseases; development of pharmaceutical preparations and pharmaceuticals, specifically for products for the treatment or prevention of cancer and infectious diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Suzhou Abogen Biosciences Co., Ltd.
- Other trademarks owned by Suzhou Abogen Biosciences Co., Ltd.
- Other trademarks owned by Suzhou Abogen Biosciences Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ABOGENBIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 5, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 5, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 15, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 15, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 15, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 24, 2025 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Jun 24, 2025 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jun 24, 2025 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jun 19, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 31, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 31, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 19, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 27, 2023 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Mar 22, 2023 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Mar 22, 2023 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Dec 15, 2022 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 22, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 22, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 2, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 18, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 18, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 18, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 18, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 12, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 23, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 23, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 17, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 16, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 3, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 30, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |